Wesley D. Kufel, PharmD, BCPS, AAHIVP
Clinical Assistant Professor, Pharmacy Practice
Office: Academic A, Room 153
- Infectious diseases
- Antimicrobial stewardship
- Pharmacy and interprofessional education
- Doctor of Pharmacy, University at Buffalo School of Pharmacy and Pharmaceutical Sciences
PGY1 Pharmacy Practice Residency: Upstate Medical University Hospital, Syracuse, N.Y.
PGY2 Infectious Diseases Pharmacy Residency: University at North Carolina Medical Center, Chapel Hill, N.C.
Wesley Kufel joins Binghamton University School of Pharmacy and Pharmaceutical Sciences as a clinical assistant professor in the Department of Pharmacy Practice. He received his Doctor of Pharmacy degree from the University at Buffalo School of Pharmacy and Pharmaceutical Sciences, completed a PGY1 Pharmacy Practice Residency at Upstate Medical University and went on to complete a PGY2 Infectious Diseases Pharmacy Residency at the University of North Carolina Medical Center. He is a board certified Pharmacotherapy Specialist (BCPS) and a certified HIV pharmacist through the American Academy of HIV Medicine.
Kufel’s clinical practice site is at Upstate Medical University Hospital where he is a clinical pharmacy specialist in infectious diseases and serves as a preceptor for pharmacy students. He provides clinical service to the infectious diseases consultation teams and antimicrobial stewardship program. He is also actively involved in interprofessional education in the area of infectious diseases.
Kufel is actively involved in multiple pharmacy organizations. He is currently on the Society of Infectious Diseases Pharmacists (SIDP) elections committee, American College of Clinical Pharmacy (ACCP) Infectious Diseases Practice and Research Network publications committee and social media committee, and the American Society of Health-System Pharmacists (ASHP) New Practitioner Forum Membership Outreach Advisory Leadership Team.
Honors and Awards:
- American College of Clinical Pharmacy (ACCP) Resident/Fellow Travel Grant (2016)
- Triangle College of Clinical Pharmacy (TCCP) Resident Travel Grant (2016)
- Merck Academic Excellence Award, University at Buffalo School of Pharmacy (2015)
- Pharmacist Society of the State of New York Outstanding Student Leader Award (2015)
- Who’s Who Among Students in American Universities and Colleges (2015)
- Pharmacist Association of Western New York Golf Scholarship (2014)
- Phi Lambda Sigma (PLS) Pharmacy Leadership Society (2014)
- Rho Chi Pharmacy Honor Society (2013)
- Society of Infectious Diseases Pharmacists (SIDP)
- Infectious Diseases Society of America (IDSA)
- American College of Clinical Pharmacy (ACCP)
- American Society of Health-System Pharmacists (ASHP)
- American Association of Colleges of Pharmacy (AACP)
Selected Peer-Reviewed Publications:
Kufel WD, Devanathan AS, Marx AH et al. Bezlotoxumab: A Novel Agent for the Prevention of Recurrent Clostridium difficile Infection. Pharmacotherapy. 2017 Jul 21. [Epub ahead of print].
Kufel WD, Williams DM, Weber DJ. Improving Immunization Practices in United States Hospitals and Health Systems. International Journal of Health Governance. 2017 Jun 28. [Epub ahead of print].
Kufel WD, Seabury RW, Meola GM, et al. Impact of Premix Antimicrobial Preparation and Time to Administration in Septic Patients. CJEM. 2016 Dec 5. [Epub ahead of print].
Kufel WD, Seabury RW, Darko W, Probst LA, Miller CD. Clinical Feasibility of Monitoring Enoxaparin Anti-Xa Concentrations: Are We Getting It Right? Hosp Pharm. 2017;52(3):214-220.
Kufel WD, Miller CD, Johnson PR, et al. Y-site Incompatibility Between Premix Concentrations of Vancomycin and Piperacillin-Tazobactam: Do Current Compatibility Testing Methodologies Tell the Whole Story? Hosp Pharm. 2017;52(2):132-137.
Kufel WD, Scrimenti A, Steele JM. A Case of Septic Shock due to Serratia marcescens Pyelonephritis and Bacteremia in a Patient Receiving Empagliflozin. J Pharm Pract. 2016 Nov 21.[Epub ahead of print].
Kufel WD, Zayac AS, Lehmann DF, Miller CD. Clinical Application and Pharmacodynamic Monitoring of Apixaban in a Patient with End-Stage Renal Disease Requiring Chronic Hemodialysis. Pharmacotherapy. 2016; 36(11):e166-e171.
Kufel WD, Hale CM, Sidman EF, et al. Review of Nucleoside Reverse Transcriptase Inhibitor (NRTI) Associated Macrocytosis. Int J Virol AIDS. 2016; 3(1):1-6.
Monte SV, Passafiume SN, Kufel WD, et al. Pharmacist home visits: A 1-year experience from a community pharmacy. J Am Pharm Assoc. 2016; 56(1):67-72.